Sintx Technologies (NASDAQ:SINT) Posts Earnings Results, Misses Expectations By $0.02 EPS

Sintx Technologies (NASDAQ:SINT) announced its quarterly earnings data on Tuesday. The company reported ($0.75) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.73) by ($0.02), FiscalAI reports. Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%.The business had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.46 million.

Here are the key takeaways from Sintx Technologies’ conference call:

• Revenue and margins improved substantially: Second-quarter revenue rose 199% year over year to $452,000, while product revenue increased 347% and gross margin expanded to 61.5% from 37.7%. Management cautioned that the gains came from a small base and margins may vary by product mix and manufacturing efficiency.
• SINTX reported purchase orders exceeding $3.2 million from existing contract-manufacturing customers, with production and shipments beginning and expected to continue into 2027. The company emphasized that converting these orders into recognized revenue will depend on production, quality release, shipment timing, customer acceptance, and cash collection.
• The SINAPTIC Foot and Ankle Osteotomy Wedge System generated initial commercial revenue after its first U.S. clinical use, but broader adoption remains dependent on surgeon education, distribution, product availability, reimbursement considerations, and market development.
• Liquidity remains a major risk: SINTX ended the quarter with $3.6 million in cash, used $5.3 million in operating cash during the first half, and disclosed substantial doubt about its ability to continue as a going concern. Management expects to pursue additional equity and/or debt financing despite approximately $5.1 million of remaining ATM capacity.
• The company continues to operate at a loss, with a second-quarter net loss of $2.7 million and first-half net loss of $5.5 million, while operating expenses increased 16% year over year. Management is evaluating staffing, facilities, outside services, inventory, and other costs as it works to align spending with commercial returns.

Sintx Technologies Stock Up 4.1%

Shares of Sintx Technologies stock traded up $0.07 on Tuesday, hitting $1.77. The stock had a trading volume of 3,699,050 shares, compared to its average volume of 63,424. Sintx Technologies has a one year low of $1.40 and a one year high of $6.78. The stock has a market cap of $7.65 million, a price-to-earnings ratio of -0.35 and a beta of 0.62. The stock’s 50-day simple moving average is $1.83 and its two-hundred day simple moving average is $2.39.

Analyst Ratings Changes

SINT has been the topic of a number of analyst reports. HC Wainwright reiterated a “buy” rating and issued a $10.00 target price on shares of Sintx Technologies in a research report on Wednesday, May 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. Finally, Maxim Group reaffirmed a “buy” rating and set a $6.00 price objective on shares of Sintx Technologies in a research note on Thursday, June 4th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $9.33.

Institutional Investors Weigh In On Sintx Technologies

A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC raised its position in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 33.5% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,339 shares of the company’s stock after buying an additional 3,848 shares during the period. Geode Capital Management LLC owned about 0.56% of Sintx Technologies worth $49,000 at the end of the most recent reporting period. 18.38% of the stock is owned by institutional investors and hedge funds.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.